MEDICINOVA, INC. Number of Reporting Units
MEDICINOVA, INC. (MNOV) reported Number of Reporting Units of 1 Reporting_unit for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes
us-gaap:NumberOfReportingUnits · last filed 2026-03-10
- MEDICINOVA, INC. number of reporting units for fiscal 2021 was 1.00 reporting_unit, a 0.00% change from fiscal 2020.
- MEDICINOVA, INC. number of reporting units for fiscal 2020 was 1.00 reporting_unit, a 0.00% change from fiscal 2019.
- MEDICINOVA, INC. number of reporting units for fiscal 2019 was 1.00 reporting_unit.
reporting_unit
| Period end | Number of Reporting Units 12 month |
|---|---|
| 2021-12-31 | 1.00 reporting_unit 10-K · filed 2022-02-16 |
| 2020-12-31 | 1.00 reporting_unit 10-K · filed 2021-02-19 |
| 2019-12-31 | 1.00 reporting_unit 10-K · filed 2020-02-13 |
Reporting_unit
| Period end | Number of Reporting Units 12 month |
|---|---|
| 2025-12-31 | 1.00 Reporting_unit 10-K · filed 2026-03-10 |
| 2024-12-31 | 1.00 Reporting_unit 10-K · filed 2025-02-19 |
| 2023-12-31 | 1.00 Reporting_unit 10-K · filed 2024-02-15 |
| 2022-12-31 | 1.00 Reporting_unit 10-K/A · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |